Baxalta Incorporated
Overview
Baxalta Incorporated was a biopharmaceutical company that focused on developing and delivering therapies for orphan diseases and underserved conditions. It is now part of Shire, which was acquired by Takeda Pharmaceutical Company. Baxalta specialized in hematology, immunology, and oncology.
Therapeutic areas
FDA compliance signals
5 FDA enforcement records linked to this company.
- 4832022-09-15
Microbiological Contamination Exam
- 4832022-09-15
Establish reliability of supplier's C of A
- 4832022-09-15
Investigations of discrepancies, failures
- 4832022-04-07
Extent of discrepancy, failure investigations
- 4832022-04-07
Validation lacking for sterile drug products
Is this Baxalta Incorporated? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.